Mr. Robert Abenante of Abattis reports

ABATTIS PARTNERS WITH VANCOUVER-BASED CRAFT BREWER TO DEVELOP HEMP-INFUSED, CANNABINOID-RICH, THC-FREE CRAFT BEER

Abattis Bioceuticals Corp. has formed a new partnership with Faculty Brewing Co., a Vancouver-based craft brewery, to develop a hemp-infused, cannabinoid-rich, THC (tetrahydrocannabinol)-free craft beer. Pursuant to a research services agreement between Abattis and Faculty Brewing, Abattis will conduct research and development activities related to the development of a hemp-infused, cannabinoid-rich, THC-free craft beer, or a line of such beers, for Faculty Brewing.

"Our exciting partnership with Faculty Brewing positions us as one of the first Canadian companies to secure an agreement for research and development, analytical, and regulatory services relating to a hemp- and cannabis-infused beverage," said Rob Abenante, president and chief executive officer of Abattis. "By aiming to develop a line of functional beers, each based on a different type of hemp extract, we hope to have a product that is compliant and market-ready as soon as Health Canada releases its new regulatory framework for hemp- and cannabis-infused beverages," added Mr. Abenante.

Northern Vine Laboratories has been contracted by Abattis to provide cannabinoid-rich, THC-free, hemp extract and to carry out research, development and analytical testing related to the formulation of a unique hemp- and cannabis-infused beer. Northern Vine is a licensed dealer under the provisions of the Canadian Controlled Drugs and Substances Act. As a licensed dealer, Northern Vine has the ability to import/export cannabis and cannabis oils, as well as the right to conduct certain activities related to the manipulation, formulation, dosage form, and strength or package size of cannabis, including mixtures with other additives, controlled substances, and non-controlled substances. Northern Vine is co-owned by Abattis and Emerald Health Therapeutics, which is a controlling shareholder.

"Having the Northern Vine team on board ensures the final product will deliver a precise and consistent amount of pesticide-free cannabinoids in every single bottle," said Dr. David Galvez, senior science adviser for Northern Vine and Abattis.

The partnership follows Abattis's Jan. 9, 2018, announcement respecting its proposed exclusive agreement to offer technical advice regarding the commercialization of cannabis products sold in British Columbia's Alliance of Beverage Licensees (ABLE BC) member stores.

Northern Vine Labs is licensed by Health Canada as a licensed dealer for the possession of cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis. Northern Vine Labs product certification and quality assurance programs incorporate global best practices and procedures for application in the legal Canadian cannabis market. Northern Vine is a subsidiary of Emerald Health Therapeutics, and Abattis retains a 47-per-cent equity interest.

About Abattis Bioceuticals Corp.

Abattis is a life sciences and biotechnology company which aggregates, integrates and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions.

We seek Safe Harbor.